Why the study?
Does preadmission beta-blocker use reduce 30-day mortality in patients over age 45 admitted to intensive care units?
Population
8,087 patients over age 45 admitted to one of three multidisciplinary intensive care units between 1999 and…
Comparison
Preadmission beta-blocker use vs Non-users of beta-blockers prior to admission
Design
Cohort
Follow-up
30 days
Authors
Loading...
Associated mortality reduction in ICU patients warrants RCTs; observational data should not yet change practice.
Does preadmission beta-blocker use reduce 30-day mortality in patients over age 45 admitted to intensive care units?
Preadmission beta-blocker use is associated with a significant reduction in 30-day mortality among patients admitted to intensive care units.
Christensen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: